Health Disparities in Germline Genetic Testing for Cancer Susceptibility
- 12 February 2020
- journal article
- research article
- Published by Springer Nature in Current Breast Cancer Reports
- Vol. 12 (2) , 51-58
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Disparities in the Diagnosis of Hypertrophic Obstructive Cardiomyopathy: A Narrative Review of Current LiteratureCardiology Research and Practice, 2018
- Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast CancerJAMA Oncology, 2018
- Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registryAtherosclerosis, 2017
- Using Genetic Technologies To Reduce, Rather Than Widen, Health DisparitiesHealth Affairs, 2016
- Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriersBMC Women's Health, 2014
- Supreme Court Ruling Broadens BRCA Testing OptionsJNCI: Journal of the National Cancer Institute, 2013
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and MortalityJAMA, 2010
- International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriersInternational Journal of Cancer, 2008
- Unequal Treatment2003
- Early use of clinical BRCA1/2 testing: Associations with race and breast cancer riskAmerican Journal of Medical Genetics Part A, 2002